Autonomix Total Other Income Expense Net from 2010 to 2026
| AMIX Stock | 0.54 0.01 1.82% |
Total Other Income Expense Net | First Reported 2010-12-31 | Previous Quarter 160.2 K | Current Value 168.2 K | Quarterly Volatility 882.5 K |
Check Autonomix Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Autonomix Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 156.5 K, Interest Expense of 94.6 K or Selling General Administrative of 5.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.42. Autonomix financial statements analysis is a perfect complement when working with Autonomix Medical Valuation or Volatility modules.
Autonomix | Total Other Income Expense Net | Build AI portfolio with Autonomix Stock |
Latest Autonomix Medical's Total Other Income Expense Net Growth Pattern
Below is the plot of the Total Other Income Expense Net of Autonomix Medical Common over the last few years. It is Autonomix Medical's Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Autonomix Medical's overall financial position and show how it may be relating to other accounts over time.
| Total Other Income Expense Net | 10 Years Trend |
|
Total Other Income Expense Net |
| Timeline |
Autonomix Total Other Income Expense Net Regression Statistics
| Arithmetic Mean | 17,478 | |
| Coefficient Of Variation | 5,049 | |
| Mean Deviation | 403,642 | |
| Median | 265,560 | |
| Standard Deviation | 882,452 | |
| Sample Variance | 778.7B | |
| Range | 3.7M | |
| R-Value | (0.30) | |
| Mean Square Error | 755.7B | |
| R-Squared | 0.09 | |
| Significance | 0.24 | |
| Slope | (52,480) | |
| Total Sum of Squares | 12.5T |
Autonomix Total Other Income Expense Net History
About Autonomix Medical Financial Statements
Autonomix Medical investors use historical fundamental indicators, such as Autonomix Medical's Total Other Income Expense Net, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Autonomix Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Other Income Expense Net | 160.2 K | 168.2 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.